0001398432-16-000599.txt : 20160415 0001398432-16-000599.hdr.sgml : 20160415 20160415154657 ACCESSION NUMBER: 0001398432-16-000599 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160414 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160415 DATE AS OF CHANGE: 20160415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENERAL CANNABIS CORP CENTRAL INDEX KEY: 0001477009 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 208096131 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54457 FILM NUMBER: 161574384 BUSINESS ADDRESS: STREET 1: 6565 EAST EVANS AVENUE CITY: DENVER STATE: CO ZIP: 80224 BUSINESS PHONE: (719) 748-5603 MAIL ADDRESS: STREET 1: 6565 EAST EVANS AVENUE CITY: DENVER STATE: CO ZIP: 80224 FORMER COMPANY: FORMER CONFORMED NAME: Advanced Cannabis Solutions, Inc. DATE OF NAME CHANGE: 20131023 FORMER COMPANY: FORMER CONFORMED NAME: Promap Corp DATE OF NAME CHANGE: 20091117 8-K 1 a12928.htm 8-K



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


                                        


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): April 14, 2016


GENERAL CANNABIS CORP

 (Exact Name of Registrant as Specified in Charter)


Colorado

000-54457

90-1072649

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer Identification Number)


6565 E. Evans Avenue
Denver, Colorado

 

80224

(Address of principal executive offices)

 

(Zip Code)


Registrant’s telephone number, including area code: (303) 759-1300


(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:


[_]

Written communications pursuant to Rule 425 under the Securities Act

[_]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[_]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

[_]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act




Item 7.01

Regulation FD Disclosure.


On April 14, 2016, General Cannabis Corp (the “Company”) issued a press release announcing the launch of its public market research services division. A copy of the press release issued by the Company is attached hereto and incorporated by reference in its entirety as Exhibit 99.1.


The information contained in this Item 7.01 of the Company’s Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The furnishing of the information in this Current Report on Form 8-K is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information contained in this Current Report on Form 8-K constitutes material investor information that is not otherwise publicly available.


The Securities and Exchange Commission encourages registrants to disclose forward-looking information so that investors can better understand the future prospects of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain these types of statements, which are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and which involve risks, uncertainties and reflect the Registrant’s judgment as of the date of this Current Report on Form 8-K. Forward-looking statements may relate to, among other things, operating results and are indicated by words or phrases such as “expects,” “should,” “will,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this Current Report on Form 8-K. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented within.


Item 9.01

Financial Statements and Exhibits.


(d) Exhibits.


The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.


Exhibit

 

Description

99.1

 

Press Release dated April 14, 2016




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Dated: April 15, 2016


 

GENERAL CANNABIS CORP

 

 

 

 

 

 

 

By:

/s/ Robert L. Frichtel

 

Name:

Robert L. Frichtel

 

Title:

Chief Executive Officer









EXHIBIT INDEX


Exhibit

 

Description

99.1

 

Press Release dated April 14, 2016














 EX-99.1 2 exh99_1.htm Exhibit

Exhibit 99.1


GENERAL CANNABIS ANNOUNCES THE LAUNCH OF GENERAL CANNABIS EQUITY RESEARCH


DENVER, CO, April 14, 2016 – General Cannabis Corporation (OTCQB: CANN) today announced the launch of its public market research services division.  The new division is called General Cannabis Equity Research or GCER.


“General Cannabis Equity Research is our first step in the building of an equity research division and leverages the unique market insight that we gain from our industry position” said Robert Frichtel, Chief Executive Officer.  “Due to the breadth of our corporate platform and team, we gain unique knowledge that we believe will add value in making investment decisions.  GCER will provide unbiased and detailed research on publicly traded companies.”


“General Cannabis noted the total absence of credible research on public companies in the sector,” said Executive Chairman Michael Feinsod.“While there are many public companies that claim to operate in the cannabis space, there is no credible source of industry and public company research.  The void creates market uncertainty and has limited access to capital for cannabis related companies.  We intend to fill that void.”


We are currently hiring individuals for the research team and expect to launch our comprehensive GCER services on July 1.


Our approach to cannabis investment research will place a high value on intrinsic value and management quality.  We will evaluate cannabis investments in the same manner as a merger and acquisitions specialist might.  Our analysis of the individual cannabis companies will be driven by economic realities of the industry and its constantly changing dynamics.


We expect our first reports to be available in July of 2016--- General Cannabis Equity Research will only be researching companies that are current in their SEC filing requirements for the March 31, 2016 quarter.


Executive Chairman Michael Feinsod added, “The cannabis industry is entering an exciting phase of national growth.  We look forward to sharing our knowledge with institutional investors as they explore and invest in the sector.”  


About


General Cannabis Corporation (www.generalcann.com) is the all-in-one resource for the highest quality service providers available to the regulated Cannabis Industry. We are a trusted partner to the cultivation, production and retail side of the cannabis business. We do this through a combination of strong operating divisions such as real estate, consulting, security, financing and the distribution of important infrastructure products to grow facilities and dispensaries. As a synergistic holding company, our subsidiaries are able to leverage the strengths of each other, as well as a larger balance sheet, to succeed.


Safe Harbor


This presentation contains forward-looking statements which relate to future events or General Cannabis’ future performance or financial condition. Any statements that are not statements of historical fact (including statements containing the words “believes,” “should,” “plans,” “anticipates,” “expects,” “estimates” and similar expressions) should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward looking statements as result of a number of factors, including those described from time to time in General Cannabis’ filings with the Securities and Exchange Commission. General Cannabis undertakes no duty to update any forward-looking statements made herein.


Contact


Robert Frichtel

CEO – General Cannabis Corp

(303) 759-1300